[go: up one dir, main page]

AU6396600A - Solid phase synthesis of oxa- and thiazoles - Google Patents

Solid phase synthesis of oxa- and thiazoles

Info

Publication number
AU6396600A
AU6396600A AU63966/00A AU6396600A AU6396600A AU 6396600 A AU6396600 A AU 6396600A AU 63966/00 A AU63966/00 A AU 63966/00A AU 6396600 A AU6396600 A AU 6396600A AU 6396600 A AU6396600 A AU 6396600A
Authority
AU
Australia
Prior art keywords
thiazoles
oxa
solid phase
phase synthesis
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63966/00A
Inventor
Barry A. Bunin
Steven P. Tushup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ChemRx Advanced Technologies Inc
Original Assignee
ChemRx Advanced Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ChemRx Advanced Technologies Inc filed Critical ChemRx Advanced Technologies Inc
Publication of AU6396600A publication Critical patent/AU6396600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11—Compounds covalently bound to a solid support
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU63966/00A 1999-08-04 2000-08-02 Solid phase synthesis of oxa- and thiazoles Abandoned AU6396600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14745199P 1999-08-04 1999-08-04
US60147451 1999-08-04
PCT/US2000/021051 WO2001010798A1 (en) 1999-08-04 2000-08-02 Solid phase synthesis of oxa- and thiazoles

Publications (1)

Publication Number Publication Date
AU6396600A true AU6396600A (en) 2001-03-05

Family

ID=22521619

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63966/00A Abandoned AU6396600A (en) 1999-08-04 2000-08-02 Solid phase synthesis of oxa- and thiazoles

Country Status (2)

Country Link
AU (1) AU6396600A (en)
WO (1) WO2001010798A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933308B2 (en) 2002-12-20 2005-08-23 Bristol-Myers Squibb Company Aminoalkyl thiazole derivatives as KCNQ modulators
US7273866B2 (en) 2002-12-20 2007-09-25 Bristol-Myers Squibb Company 2-aryl thiazole derivatives as KCNQ modulators
DE102004051277A1 (en) 2004-10-21 2006-04-27 Merck Patent Gmbh Heterocyclic carbonyl compounds
JP5584696B2 (en) * 2008-11-17 2014-09-03 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Heteroaryl diamide compounds useful as MMP-13 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700821A (en) * 1996-07-30 1997-12-23 University Of Pittsburgh Phosphatase inhibitors and methods of use thereof
AU4997199A (en) * 1998-07-16 2000-02-07 Axys Pharmaceuticals, Inc. Process for the synthesis of benzopyran derivatives

Also Published As

Publication number Publication date
WO2001010798A1 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
AU3771100A (en) Synthesis of epothilones
AU7830400A (en) Synthesis of insulin derivatives
AUPQ377899A0 (en) Phase three kernel selection
AU3565999A (en) Synthesis of azetidine derivatives
AU2001269063A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
AU6432800A (en) Process for the synthesis of citalopram
AUPQ137699A0 (en) Control of acidosis
AU7302000A (en) Phase change mechanism
AU5587200A (en) Synthesis of substituted amidines
AU4945697A (en) Solid phase synthesis of heterocyclic compounds
AU2002316593A1 (en) Solid phase synthesis of arylretinamides
AU6396600A (en) Solid phase synthesis of oxa- and thiazoles
AU4991300A (en) Processes for the synthesis of oligomers using phusphoramidite compositions
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
NO20010637D0 (en) Solid phase synthesis of thio-oligosaccharides
AU2402600A (en) Pentafulvene synthesis
AU2565900A (en) Mixtures of materials
AU4937700A (en) Process for the preparation of supports for solid phase synthesis
AU3739300A (en) Synthesis of vapol ligands
AU7711800A (en) Novel uses of 2-bromopalmitate
AU7961800A (en) Thiazolidinedione derivatives
AU4242100A (en) Methods for solid phase combinatorial synthesis of integrin inhibitors
AU3894800A (en) Solid phase synthesis of benzodiazepine diones
AU5403100A (en) Enforced expression of bcl-xl
AU2576601A (en) Novel supports for solid phase synthesis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase